The role of raw materials --- I'd like to bring into the discussion that efforts in R&D can be frustrated by the concentration in few countries of the production of generic active pharmaceutical ingredients (APIs), with India and China representing alone >60% of world production. This can have a strong impact on ensuring citizens’ access to safe, effective and high-quality medicines at an affordable price, and also become a 'bagaining chip' in regional or global disputes...

Source author: Veronica Elena Bocci v_ele_bo@hotmail.com